Summary of opinion: Infanrix Hexa, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Infanrix Hexa, 27/06/2024 Positive
Summary of opinion: Infanrix Hexa, 27/06/2024 Positive
Summary of opinion: Xalkori, 27/06/2024 Positive
Positive CHMP opinion on first-in-class medicine to treat pulmonary arterial hypertension
EMA recommends revoking conditional marketing authorisation for Ocaliva
First nasal adrenaline spray for emergency treatment against allergic reactions
Summary of opinion: Imfinzi, 27/06/2024 Positive
Summary of opinion: Lynparza, 27/06/2024 Positive
Questions and answers on classification of veterinary medicinal products
Minutes of the CVMP meeting 21-22 May 2024
Committee for Medicinal Products for Veterinary Use (CVMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024